PolyPid
PYPD
PolyPid (PYPD) news
Recent news
PolyPid - U.S. launch of D-Plex100 targeted for Q1 2027
PolyPid Ltd. has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for D-PLEX100, a locally delivered antibiotic depot intended to prevent surgical site infections (SSIs) following colorectal surgery. The NDA submission began on March 30, 2026, with the…
AInvest Wire · Jul 21, 2026PolyPid - to receive $15 mln upfront and $15 mln on FDA NDA acceptance
AInvest Wire · Jul 21, 2026PolyPid - eligible for up to $300 mln in additional milestone payments
AInvest Wire · Jul 21, 2026PolyPid says it could receive more than $320 million in upfront and milestone payments
AInvest Wire · Jul 21, 2026PolyPid - FDA decision on D-Plex100 expected in Q1 2027 under PDUFA timeline
AInvest Wire · Jun 1, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.